Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Products to Advance Research on Human Pluripotent Stem Cells

Published: Wednesday, June 13, 2012
Last Updated: Wednesday, June 13, 2012
Bookmark and Share
STEMCELL to launch TeSR-E8 - a novel medium for human embryonic and induced pluripotent stem cells - and new STEMdiff kits for differentiation of these cell types.

STEMCELL Technologies Inc. (STEMCELL) has announced that its plans to release a series of new products to advance research and translational applications for human pluripotent stem cells.

These novel products, which will be launched at the International Society for Stem Cell Research 2012 Conference in Japan, include:

TeSR™-E8™: a highly defined feeder-free culture medium for human embryonic stem cells (ES cells) and human induced pluripotent stem cells (iPS cells).

TeSR-E8 contains only the most essential 8 components required for maintenance of ES cells and iPS cells, providing a simpler medium for the culture of pluripotent stem cells. It is based on the E8 formulation published in Nature Methods (G. Chen et al., Nature Methods 8, 424 (2011)). This lab previously developed the mTeSR™1 and TeSR™2 feeder-free culture media, which were licensed and commercialized by STEMCELL Technologies and are now the most widely-published feeder-free culture media for human pluripotent stem cells.

TeSR-E8 can be used with a surface coating of BD Matrigel™ hESC-qualified Matrix or vitronectin, as described in this publication. It will be available for purchase in September 2012 under the license agreement that STEMCELL has with the Wisconsin Alumni Research Foundation (WARF).

STEMdiff™ Definitive Endoderm / Cardiomyocyte / Hematopoietic kits: the STEMdiff product line is significantly expanded with the world's first complete commercial kits for directed hPSC differentiation to definitive endoderm, cardiomyocyte and hematopoietic lineages. These new kits will be available for purchase in October 2012.

STEMdiff products provide robust reagents and protocols to reliably differentiate hPSC to various lineages and are optimized for use with mTeSR™1 and TeSR™2 feeder-free culture media.

"We are delighted to build on our track record for providing high quality cell culture media to stem cell scientists, by introducing new products that work as an integrated system," said Dr. Allen Eaves, CEO and President of STEMCELL Technologies. "We are excited to give scientists products that are designed to work together and extend from reprogramming through to differentiation."

By adding TeSR-E8 and the new STEMdiff kits to its portfolio, STEMCELL Technologies continues to provide the most complete, defined system of integrated tools for human pluripotent stem cell research.

These high-quality reagents for defined pluripotent cell culture increase experimental reproducibility, eliminate variable biologic elements in the culture media and increase clinical relevance for culture of ES cells and iPS cells.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

STEMCELL Technologies Inc Launches new Website
Company announces a redesigned website for embryonic stem cell research, cord blood banking, HIV and immunology.
Friday, June 18, 2010
STEMCELL Technologies Inc. Announces Direct Distribution to Spain
According to Company, customers in Spain will have immediate access to in-house scientists and its technical support team.
Friday, October 09, 2009
STEMCELL Technologies Launches Direct Distribution to Singapore
STEMCELL announces the opening of a new sales and distribution office in Singapore, effective January 12th, 2009.
Wednesday, January 14, 2009
Scientific News
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Reclaiming The Immune System's Assault On Tumors
EPFL study shows a way to reclaim corrupted immune cells.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
Cirrhosis-Causing Cells Converted to Healthy Liver Cells in Mice
New approach that repairs liver from within may be more efficient than cell transplants.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!